Found: 18
Select item for more details and to access through your institution.
Helicobacter pylori eradication rates with concomitant and tailored therapy based on 23S rRNA point mutation: A multicenter randomized controlled trial.
- Published in:
- Helicobacter, 2019, v. 24, n. 5, p. N.PAG, doi. 10.1111/hel.12654
- By:
- Publication type:
- Article
A lucid review of Helicobacter pylori‐induced DNA damage in gastric cancer.
- Published in:
- Helicobacter, 2019, v. 24, n. 5, p. N.PAG, doi. 10.1111/hel.12631
- By:
- Publication type:
- Article
Helicobacter pylori‐activated gastric fibroblasts induce epithelial‐mesenchymal transition of gastric epithelial cells in vitro in a TGF‐β‐dependent manner.
- Published in:
- Helicobacter, 2019, v. 24, n. 5, p. N.PAG, doi. 10.1111/hel.12653
- By:
- Publication type:
- Article
Effect of vitamin D on Helicobacter pylori infection and eradication: A meta‐analysis.
- Published in:
- Helicobacter, 2019, v. 24, n. 5, p. N.PAG, doi. 10.1111/hel.12655
- By:
- Publication type:
- Article
Protocol of the European Registry on the management of Helicobacter pylori infection (Hp‐EuReg).
- Published in:
- Helicobacter, 2019, v. 24, n. 5, p. N.PAG, doi. 10.1111/hel.12630
- By:
- Publication type:
- Article
Evolution of Helicobacter pylori associated with gastroduodenal ulcers or erosions in children over the past 23 years: Decline or steady state?
- Published in:
- Helicobacter, 2019, v. 24, n. 5, p. N.PAG, doi. 10.1111/hel.12629
- By:
- Publication type:
- Article
Vaccine‐induced gastric CD4<sup>+</sup> tissue‐resident memory T cells proliferate in situ to amplify immune response against Helicobacter pylori insult.
- Published in:
- Helicobacter, 2019, v. 24, n. 5, p. N.PAG, doi. 10.1111/hel.12652
- By:
- Publication type:
- Article
New insights into resistance of Helicobacter pylori against third‐ and fourth‐generation fluoroquinolones: A molecular docking study of prevalent GyrA mutations.
- Published in:
- Helicobacter, 2019, v. 24, n. 5, p. N.PAG, doi. 10.1111/hel.12628
- By:
- Publication type:
- Article
Saccharomyces boulardii as an adjuvant therapy for Helicobacter pylori eradication: A systematic review and meta‐analysis with trial sequential analysis.
- Published in:
- Helicobacter, 2019, v. 24, n. 5, p. N.PAG, doi. 10.1111/hel.12651
- By:
- Publication type:
- Article
Combined effect between WT1 methylation and Helicobacter pylori infection, smoking, and alcohol consumption on the risk of gastric cancer.
- Published in:
- Helicobacter, 2019, v. 24, n. 5, p. N.PAG, doi. 10.1111/hel.12650
- By:
- Publication type:
- Article
Online registry for nationwide database of Helicobacter pylori eradication in Korea: Correlation of antibiotic use density with eradication success.
- Published in:
- Helicobacter, 2019, v. 24, n. 5, p. N.PAG, doi. 10.1111/hel.12646
- By:
- Publication type:
- Article
Detection of Helicobacter pylori with clarithromycin resistance‐associated mutations using peptide nucleic acid probe‐based melting point analysis.
- Published in:
- Helicobacter, 2019, v. 24, n. 5, p. N.PAG, doi. 10.1111/hel.12634
- By:
- Publication type:
- Article
Increasing antimicrobial resistance to clarithromycin and metronidazole in pediatric Helicobacter pylori infection in southern Taiwan: A comparison between two decades.
- Published in:
- Helicobacter, 2019, v. 24, n. 5, p. N.PAG, doi. 10.1111/hel.12633
- By:
- Publication type:
- Article
The relationship between Helicobacter pylori infection and depressive symptoms in the general population in China: The TCLSIH cohort study.
- Published in:
- Helicobacter, 2019, v. 24, n. 5, p. N.PAG, doi. 10.1111/hel.12632
- By:
- Publication type:
- Article
The clinical meaning of the "indefinite for atrophy" lesions within gastric mucosa biopsy specimens in a region with a high prevalence of gastric cancer.
- Published in:
- Helicobacter, 2019, v. 24, n. 5, p. N.PAG, doi. 10.1111/hel.12605
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Helicobacter, 2019, v. 24, n. 5, p. N.PAG, doi. 10.1111/hel.12509
- Publication type:
- Article
Once‐daily rabeprazole, levofloxacin, clarithromycin‐MR, and bismuth for Helicobacter pylori eradication: A randomized study of 7 or 14 days (ONCE study).
- Published in:
- Helicobacter, 2019, v. 24, n. 5, p. N.PAG, doi. 10.1111/hel.12615
- By:
- Publication type:
- Article
Pylera® plus ranitidine vs Pylera® plus esomeprazole in first‐line treatment of Helicobacter pylori infection: Two pilot studies.
- Published in:
- Helicobacter, 2019, v. 24, n. 5, p. N.PAG, doi. 10.1111/hel.12606
- By:
- Publication type:
- Article